{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:02:12Z","timestamp":1793073732129,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.suronc.2026.102437","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:02:55Z","timestamp":1776697375000},"page":"102437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Colorectal peritoneal metastases treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Should we consider the primary tumour site?"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5514-9665","authenticated-orcid":false,"given":"Fatah","family":"Tidadini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Sourrouille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Eveno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koceila Lamine","family":"Amroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Abba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pocard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahan","family":"Kepenekian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fernandez de Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Louis-Gaubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Foote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Sage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice","family":"Malgras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Trilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Faucheron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-C\u00e9cile","family":"Ezanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Arvieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.suronc.2026.102437_bib2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.suronc.2026.102437_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/bjs.8679","article-title":"Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer","volume":"99","author":"Segelman","year":"2012","journal-title":"Br. J. Surg."},{"issue":"12","key":"10.1016\/j.suronc.2026.102437_bib4","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in cancers of the digestive system (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.suronc.2026.102437_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s00261-024-04595-z","article-title":"Imaging in malignant peritoneal neoplasms","author":"Srinivas Rao","year":"2024","journal-title":"Abdom. Radiol."},{"issue":"8","key":"10.1016\/j.suronc.2026.102437_bib6","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3390\/jcm13082238","article-title":"It is what the surgeon does not see that kills the patient","volume":"13","author":"Sugarbaker","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.suronc.2026.102437_bib7","article-title":"ASO author reflections: evolving paradigms in the management of peritoneal metastases recurrences: repeat cytoreductive surgery with HIPEC or not-insights from French expert centers","author":"Arvieux","year":"2024","journal-title":"Ann. Surg Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2026.102437_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/DCR.0b013e3181c703a4","article-title":"Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival","volume":"53","author":"Benedix","year":"2010","journal-title":"Dis. Colon Rectum"},{"issue":"2","key":"10.1016\/j.suronc.2026.102437_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/DCR.0000000000003477","article-title":"Final results of the GRECCAR-6 trial on waiting period following neoadjuvant radiochemotherapy for locally advanced rectal cancer: 5 years of Follow-up","volume":"68","author":"Collard","year":"2025","journal-title":"Dis. Colon Rectum"},{"issue":"10","key":"10.1016\/j.suronc.2026.102437_bib10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","article-title":"Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial","volume":"35","author":"Conroy","year":"2024","journal-title":"Ann. Oncol."},{"issue":"10139","key":"10.1016\/j.suronc.2026.102437_bib11","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","article-title":"Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study","volume":"391","author":"van der Valk","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.suronc.2026.102437_bib12","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.ejso.2019.06.020","article-title":"Colic and rectal tumors with peritoneal metastases treated with cytoreductive surgery and HIPEC: one homogeneous condition or two different diseases? A systematic review and meta-analysis","volume":"45","author":"Tonello","year":"2019","journal-title":"Eur. J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2026.102437_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jso.21061","article-title":"Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion","volume":"98","author":"Glehen","year":"2008","journal-title":"J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.suronc.2026.102437_bib15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.4251\/wjgo.v12.i7.756","article-title":"Comparison of open and closed hyperthermic intraperitoneal chemotherapy: results from the United States hyperthermic intraperitoneal chemotherapy collaborative","volume":"12","author":"Leiting","year":"2020","journal-title":"World J. Gastrointest. Oncol."},{"issue":"13","key":"10.1016\/j.suronc.2026.102437_bib16","doi-asserted-by":"crossref","first-page":"9098","DOI":"10.1245\/s10434-021-10193-w","article-title":"HIPEC methodology and regimens: the need for an expert consensus","volume":"28","author":"Bhatt","year":"2021","journal-title":"Ann. Surg Oncol."},{"issue":"8","key":"10.1016\/j.suronc.2026.102437_bib17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10434-999-0790-0","article-title":"Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique","volume":"6","author":"Stephens","year":"1999","journal-title":"Ann. Surg Oncol."},{"issue":"1","key":"10.1016\/j.suronc.2026.102437_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00000658-198807000-00005","article-title":"Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding","volume":"208","author":"Fujimoto","year":"1988","journal-title":"Ann. Surg."},{"issue":"9","key":"10.1016\/j.suronc.2026.102437_bib19","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1245\/s10434-011-1651-1","article-title":"Closed abdomen hyperthermic intraperitoneal chemotherapy with irinotecan and mitomycin C: a phase I study","volume":"18","author":"Cotte","year":"2011","journal-title":"Ann. Surg Oncol."},{"issue":"10","key":"10.1016\/j.suronc.2026.102437_bib20","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s12094-018-1857-9","article-title":"Peritoneal carcinomatosis arising from rectal or colonic adenocarcinoma treated with cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC): two different diseases","volume":"20","author":"Tonello","year":"2018","journal-title":"Clin. Transl. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2026.102437_bib21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s11605-015-3026-6","article-title":"The worse prognosis of right-sided compared with left-sided Colon cancers: a systematic review and meta-analysis","volume":"20","author":"Yahagi","year":"2016","journal-title":"J. Gastrointest. Surg."},{"issue":"8","key":"10.1016\/j.suronc.2026.102437_bib22","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/annonc\/mdx175","article-title":"Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials","volume":"28","author":"Arnold","year":"2017","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2026.102437_bib23","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","article-title":"Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer","volume":"203","author":"da Silva","year":"2006","journal-title":"J. Am. Coll. Surg."},{"issue":"3","key":"10.1016\/j.suronc.2026.102437_bib24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/02656736.2016.1262064","article-title":"201 consecutive cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in a single Asian tertiary centre","volume":"33","author":"Tan","year":"2017","journal-title":"Int. J. Hyperther."},{"issue":"7","key":"10.1016\/j.suronc.2026.102437_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0325941","article-title":"Impact of body mass index on surgical and oncological outcomes after Hyperthermic Intraperitoneal Chemotherapy (HIPEC)","volume":"20","author":"Ezanno","year":"2025","journal-title":"PLoS One"},{"issue":"42","key":"10.1016\/j.suronc.2026.102437_bib26","article-title":"The impact of body mass index on the surgical outcomes of patients with gastric cancer: a 10-Year, single-institution cohort study","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltim.)"},{"issue":"8","key":"10.1016\/j.suronc.2026.102437_bib27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa055643","article-title":"Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old","volume":"355","author":"Adams","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.suronc.2026.102437_bib28","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1007\/s12094-023-03155-z","article-title":"Morbimortality after 1321 consecutive CRS + HIPEC procedures: seeking excellence in surgery for peritoneal surface malignancy","volume":"25","author":"Ramos Bernad\u00f3","year":"2023","journal-title":"Clin. Transl. Oncol."},{"issue":"7","key":"10.1016\/j.suronc.2026.102437_bib29","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1245\/s10434-020-09301-z","article-title":"In-Hospital mortality and complication rates according to health insurance data in patients undergoing hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies in Germany","volume":"28","author":"\u00dcberr\u00fcck","year":"2021","journal-title":"Ann. Surg Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2026.102437_bib30","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/SLA.0000000000001991","article-title":"To drain or not to drain infraperitoneal anastomosis after rectal excision for cancer: the GRECCAR 5 randomized trial","volume":"265","author":"Denost","year":"2017","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.suronc.2026.102437_bib31","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/jso.27885","article-title":"Review of 2022 PSOGI\/RENAPE consensus on HIPEC","volume":"130","author":"Kusamura","year":"2024","journal-title":"J. Surg. Oncol."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740426000885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740426000885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:03:42Z","timestamp":1780664622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740426000885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":29,"alternative-id":["S0960740426000885"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102437","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colorectal peritoneal metastases treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Should we consider the primary tumour site?","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102437"}}